Skip to main content
VCbacked
Log inGet Started

Purespring Therapeutics

London, United Kingdom

Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.

$104.5M raised
Oct 2024
Series B
BiotechnologyMedicalTherapeutics

Top Investors

Sofinnova PartnersForbion Capital PartnersGilde HealthcareBritish Patient CapitalSyncona Partners LLP

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Purespring Therapeutics

How much funding has Purespring Therapeutics raised?
Purespring Therapeutics has raised $104.5M in total funding. The most recent round was Series B. The last funding was announced in October 2024.
Who are Purespring Therapeutics's investors?
Purespring Therapeutics's investors include Sofinnova Partners, Forbion Capital Partners, Gilde Healthcare, British Patient Capital, Syncona Partners LLP.
Where is Purespring Therapeutics headquartered?
Purespring Therapeutics is headquartered in London, United Kingdom.
What does Purespring Therapeutics do?
Purespring Therapeutics is a gene therapy company that provides treatments for different kidney diseases.
What stage is Purespring Therapeutics at?
Purespring Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Purespring Therapeutics — Funding & Investors." VCBacked, October 9, 2024, https://www.vcbacked.co/company/purespring-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2024). Purespring Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/purespring-therapeutics
Wikipedia (cite web)
{{cite web |title=Purespring Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/purespring-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong